*  Anti-neutrophil cytoplasmic antibody
This releases free oxygen radicals and lytic enzymes, resulting in damage to the endothelium via the induction of necrosis and ... clinical remission correlates more to the decreasing number of circulating B-cells than decrease in ANCA titre, which in some ...
*  Management of ulcerative colitis
The concept of induction of remission and maintenance of remission is very important. The medications used to induce and ... During remission the membrane is reestablished, but may be subject to new damage, resulting in a flare up of the disease. To ... Once remission is induced, maintenance levels can be used: sulfasalazine 2 g/day, mesalamine 1.2-2.4 g/day, or olsalazine 1 g/ ... The free radical induction theory, discussed below, proposes that 5-ASA is serving not just as an anti-inflammatory agent, but ...
*  Acute lymphoblastic leukemia
It is estimated that 60-80% of adults undergoing induction chemotherapy achieve complete remission after 4 weeks, and those ... Chemotherapy for ALL consists of three phases: remission induction, intensification, and maintenance therapy. Due to presence ... in their ALL after initial treatment have a poorer prognosis than those who remain in complete remission after induction ... These patients in relapse may also receive blinatumomab, as it has shown to increase remission rates and overall survival rates ...
*  List of patient-reported quality of life surveys
Bejarano, V.; Conaghan, P. G.; Quinn, M. A.; Saleem, B.; Emery, P. (2010). "Benefits 8 years after a remission induction regime ...
*  The Rheumatoid Arthritis Quality of Life Questionnaire
"Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid ...
*  Granulomatosis with polyangiitis
... induction of remission with initial immunosuppressive therapy, and maintenance of remission with immunosuppressive therapy for ... The standard treatment for GPA is cyclophosphamide and high dose corticosteroids for remission induction and less toxic ... Once remission has been achieved, azathioprine and steroids can be used to maintain remission. In severe kidney vasculitis, the ... Some patients are able to lead relatively normal lives and remain in remission for 20+ years after treatment. The incidence is ...
*  Acute biphenotypic leukaemia
... asparaginase or daunorubicin is common for BAL remission induction therapy. Recently, researches showed that using both myeloid ... The induction drug for AML such as cytarabine and anthracycline, drug for ALL such as prednisolone, dexamethasone, vincristine ... BAL is difficult to treat, most patients receive treatment based on the morphology of blasts and get AML or ALL induction ... Medical Blood Institute reported cases of CR rate was 31.6%, with a median remission are less than 6 months The median survival ...
*  Crohn's disease
"Natalizumab for induction of remission in Crohn's disease". Cochrane Database of Systematic Reviews (1): CD006097. doi:10.1002/ ... Srinivasan, R; Akobeng, AK (Apr 15, 2009). "Thalidomide and thalidomide analogues for induction of remission in Crohn's disease ... There is no cure for Crohn's disease and remission may not be possible or prolonged if achieved. In cases where remission is ... "Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease". The Cochrane Database of Systematic Reviews (5): ...
*  Etrolizumab
... for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2015 Dec 2;12:CD011661. PMID 26630451 ... As of 2016 it was in phase III studies for induction and maintenance therapy in people with ulcerative colitis and Crohn's. ...
*  Intestinal permeability
Akobeng, AK; Elawad, M; Gordon, M (8 February 2016). "Glutamine for induction of remission in Crohn's disease". The Cochrane ...
*  Ulcerative colitis
The concept of induction of remission and maintenance of remission is very important. The medications used to induce and ... Chande, N; Wang, Y; MacDonald, JK; McDonald, JW (27 August 2014). "Methotrexate for induction of remission in ulcerative ... Patients with more extensive disease are less likely to sustain remission, but the rate of remission is independent of the ... Specific types of probiotics such as Escherichia coli Nissle have been shown to induce remission in some patients for up to a ...
*  DHAP (chemotherapy)
DHAP in context of chemotherapy is an acronym for chemotherapy regimen that is used for remission induction in cases of ...
*  Low-dose naltrexone
Segal, D; Macdonald, JK; Chande, N (Feb 21, 2014). "Low dose naltrexone for induction of remission in Crohn's disease". The ...
*  Tacrolimus
"Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis". Cochrane Database Syst Rev. 16 (3): CD007216. ...
*  Management of Crohn's disease
In January 2008, the FDA approved natalizumab for both induction of remission and maintenance of remission for moderate to ... The most commonly prescribed oral steroid is prednisone, which is typically dosed at 0.5 mg/kg for induction of remission in ... Infliximab has found utility as follows: Induction and maintenance of remission for people with Crohn's disease Maintenance for ... Lim, Wee-Chian; Hanauer, Stephen (2010). "Aminosalicylates for induction of remission or response in Crohn's disease". Cochrane ...
*  7+3 (chemotherapy)
... as first-line induction therapy (to induce remission) in acute myelogenous leukemia, excluding the acute promyelocytic leukemia ... induction regimens). It gave rise to the so-called ADE (or DAE = DA + etoposide) induction regimen in AML. The ADE induction ( ... therapy for previously untreated adult patients with acute myeloid leukemia Comparison of three remission induction regimens ... Cytarabine plus idarubicin or daunorubicin as induction and consolidation ...
*  Volasertib
Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2). ... Holtrich, U.; G. Wolf; A. Brauninger; T. Karn; B. Bohme; H. Rubsamen-Waigmann; K. Strebhardt (1994). "Induction and down- ...
*  Index of oncology articles
... remission induction therapy - remote brachytherapy - renal cell cancer - renal collecting tubule - renal glomerulus - renal ... cancer induction - Cancer Information Service - cancer of unknown primary origin - Cancer stem cell - cancer vaccine - Cancer. ... partial remission - partial response - passive antibody therapy - Paterson-Kelly syndrome - pathological staging - patient- ... complete remission - complete response - compound nevus - compression bandage - computed tomographic colonography - computed ...
*  Budesonide
... assists in the induction of remission in people with active ulcerative colitis. Budesonide is highly effective and ... for induction and maintenance of remission, and for both the lymphocytic colitis and collagenous colitis forms. Nasal spray ... A Cochrane review found evidence for up to 3 months (but not longer) of maintenance of remission Crohn's disease. ... 2014). "Budesonide for maintenance of remission in Crohn's disease". Cochrane Database Syst Rev. 8: CD002913. doi:10.1002/ ...
*  IgG4-related disease
Following a successful induction of remission, maintenance therapy might be given in some cases, for example when there is a ... The goal of treatment is the induction and maintenance of remission so as to prevent progression of fibrosis and organ ... In untreated patients with active disease, the recommended first-line agent for induction of remission is glucocorticoids ... Although not validated yet in clinical trials, the common induction regime is prednisolone 30-40 mg per day for 2-4 weeks, then ...
*  Mutaflor
Induction and maintenance of remission with nonpathogenic Escherichia coli in patients with pouchitis. Am J Gastroenterol 2001; ... Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol. 2004 Oct1;42( ... Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard ... NF-ÊB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917:a ...
*  Certolizumab pegol
... is safe and effective in the maintenance of response and remission following induction in active Crohn's disease: a phase 3 ... Maintained Remission and Response in Recent Onset Crohn's Disease" (Press release). UCB. October 23, 2006. Retrieved 2009-11-15 ...
*  Mesalazine
... evidence-based treatment algorithms for induction and maintenance of remission". Alimentary Pharmacology & Therapeutics. 26 (7 ... and to maintain remission in Crohn's disease. It is sold in an oral form to maintain remission in Crohn's disease, and as a ...
*  Natalizumab
In January 2008, the FDA approved natalizumab for both induction of remission and maintenance of remission for moderate to ... 2007). "Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while ... Several randomized controlled trials have demonstrated that natalizumab is effective in increasing rates of remission and ... as well as increasing rates of remission and preventing relapse in Crohn's disease. Natalizumab was approved in 2004 by the U.S ...
*  Tumor antigens recognized by T lymphocytes
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell ... Complete remissions have been observed in leukemic patients infused with T cells genetically engineered to carry an artificial ... Chimeric antigen receptor T cells for sustained remissions in leukemia ". The New England Journal of Medicine. 371(16): 1507- ...
*  Diane Geppi-Aikens
She was the youngest person ever to be honored with this induction. Geppi-Aikens became the head coach of the Loyola Greyhounds ... In 2001, during a period a remission from her cancer, Geppi-Aikens was inducted into the U.S. Lacrosse Greater Baltimore ...
*  Leukemia
Induction chemotherapy to bring about bone marrow remission. For adults, standard induction plans include prednisone, ... In most cases, one round of treatment will produce a prolonged remission. Other treatments include rituximab infusion or self- ... Else, M., Ruchlemer, R., Osuji, N. (2005). "Long remissions in hairy cell leukemia with purine analogs: a report of 219 ... Dearden CE, Matutes E, Cazin B (September 2001). "High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H". Blood ...